| Article
Both the central nervous system and the peripheral nervous system are heavily involved in starting and continuing a migraine attack, and are involved before the migraine even starts. If you divide a migraine into premonitory phases–the aura, the migraine phase and then the postdrome, with modern...
| Video
Dr. Ward discusses points of differential diagnosis and strategies for treatment selection that can promote better outcomes for migraine sufferers. The Migraine Treatment Optimization Questionnaire is a tool that can help the clinician address unmet needs for their patients.
| Video
The American Headache Society's chronic Migraine Education Program (CMEP) was presented as part of the curriculum at PAINWeek 2017. In the segment, panelist Kathleen Digre, MD, discusses the interaction of central and peripheral nervous systems in triggering a migraine attack, the longer-term...
| Video
Approximately 1 billion people in the world are affected by migraine, and some 40% are estimated to be candidates for preventative therapy. Dr. Vargas outlines some objectives and principles for treating this patient population. New medications and therapies on the horizon point to better outcomes...
| Article
Survivors of a terror attack are at elevated risk for frequent migraine and tension headache, suggests the conclusions from a recent study in Norway. The investigation centered on the teenage survivors of the 2011 incident at a summer youth camp on Utoya Island in which a gunman killed 69 campers...
| Article
Results of a recent phase III clinical trial confirm the efficacy and safety of a novel antibody therapy in reducing the number of days of headache experienced by chronic migraine sufferers. The findings from the HALO CM trial, resorted by researchers from Thomas Jefferson University Hospital,...
| Article
Results from a small randomized trial suggest that botulinum toxin injections may be an effective alternative therapy for migraine headache in children and teens that is refractory to standard treatment approaches. Currently, botulinum toxin is FDA approved for treating migraine in adults only, and...
| Article
Findings from a retrospective study of patients with intractable migraine headache suggest that ketamine may be an effective treatment option. The review of data for 61 patients whose migraine had failed other treatments found that almost 75% reported reduced headache intensity following a 3- to 7...
| Article
While seeking to uncover evidence of racial disparities in the treatment of migraine, researchers at University of Michigan Medical School documented an entirely different problem: overuse of opioids as migraine therapy across all racial groups. Based on the knowledge that African-Americans are at...
| Article
Researchers at Beth Israel Deaconess Medical Center, Boston, have reported that exposure to light can cause migraine sufferers to experience changes in mood and negatively impact a range of physiological parameters including heart rate, breathing, fatigue, nausea and congestion. The findings advance...